ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Melanocytic naevus | 23.10.01.007; 16.26.01.007 | 0.001865% | | Not Available |
Memory impairment | 19.20.01.003; 17.03.02.003 | - | - | |
Metastases to liver | 16.22.02.001; 09.04.02.004 | 0.000347% | | Not Available |
Metastases to lung | 22.08.01.005; 16.22.02.002 | 0.000347% | | Not Available |
Metastatic malignant melanoma | 23.08.01.002; 16.03.01.002 | 0.000903% | | Not Available |
Muscle spasms | 15.05.03.004 | - | - | |
Muscular weakness | 17.05.03.005; 15.05.06.001 | - | - | |
Musculoskeletal pain | 15.03.04.007 | 0.000799% | | |
Myalgia | 15.05.02.001 | 0.005861% | | |
Mydriasis | 17.02.11.003; 06.05.03.004 | 0.000533% | | Not Available |
Myocardial infarction | 24.04.04.009; 02.02.02.007 | - | - | |
Myocardial ischaemia | 24.04.04.010; 02.02.02.008 | 0.000533% | | Not Available |
Nasopharyngitis | 22.07.03.002; 11.01.13.002 | 0.001332% | | Not Available |
Nausea | 07.01.07.001 | 0.012521% | | |
Neck pain | 15.03.04.009 | 0.000533% | | |
Neoplasm | 16.16.02.001 | - | - | Not Available |
Neoplasm malignant | 16.16.01.001 | - | - | Not Available |
Nephritis | 20.05.02.001 | - | - | Not Available |
Nephropathy | 20.05.03.001 | - | - | Not Available |
Nervous system disorder | 17.02.10.001 | 0.000533% | | Not Available |
Neuropathy peripheral | 17.09.03.003 | 0.001066% | | Not Available |
Neutropenia | 01.02.03.004 | - | - | Not Available |
Neutrophil count increased | 13.01.06.011 | 0.000533% | | Not Available |
Night sweats | 23.02.03.006; 08.01.03.031 | 0.000799% | | Not Available |
Ocular hyperaemia | 06.04.05.004 | 0.000533% | | Not Available |
Oedema | 14.05.06.010; 08.01.07.006 | 0.000799% | | Not Available |
Oedema peripheral | 14.05.06.011; 08.01.07.007; 02.05.04.007 | 0.001332% | | |
Pain | 08.01.08.004 | 0.004795% | | |
Pain in extremity | 15.03.04.010 | 0.004263% | | |
Palmar-plantar erythrodysaesthesia syndrome | 23.07.04.001; 17.02.07.009 | 0.002664% | | |